Bayer HealthCare is pleased to announce Baycox® 5% is now approved to prevent clinical signs of coccidiosis and to reduce coccidian shedding in lambs caused by Eimeria crandallis and Eimeria ovinoidalis. Canadian veterinarians and producers can now use Baycox 5% to protect lambs from the infection and avoid serious economic losses.
In 2010, Health Canada approved Baycox 5% for the treatment of preclinical cocidiosis due to Isospora suis in neonatal piglets.
Baycox 5% is a single-dose, ready-to-use product that is easy to administer. A single oral treatment of Baycox controls coccidia infection without impairing the ability of animals to acquire immunity, and promotes resistance to reinfection.
See news release below for additional information.